Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies
Clinical Genetics · 2025-01 · 107 (1) · 91-97
DOI: 10.1111/cge.14622 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 05.10.2024. Verfasst von Antonia M Stehr und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health, Institute of Human Genetics, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Plasma Membrane Calcium-Transporting ATPases, Mutation, Neurodevelopmental Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: EJP RD Joint Transnational Call 2022, German Research Foundation, Else Kröner-Fresenius-Stiftung.
Abstract (Originalsprache)
Plasma membrane calcium ATPases (PMCAs) encoded by ATP2B genes have been implicated in Mendelian diseases with ataxia, dystonia, and intellectual disability. Work to date has shown that ATP2B2 (encoding PMCA2) is required for synaptic function and Purkinje‐cell integrity in the cerebellum. A recent case series has linked ATP2B2 to a novel entity, characterized by neurodevelopmental and movement phenotypes, in only seven individuals. We called for collaboration to collect five unpublished families affected by the new rare ATP2B2 ‐related condition. Exome‐/genome sequencing‐identified genotypes included four likely pathogenic/pathogenic heterozygous de novo missense variants and one dominantly inherited end‐truncating frameshift allele. The six affected individuals shared features with the described patients including developmental delay, cognitive disturbances, epilepsy, autistic traits, and motor disorders. Striking cerebellar atrophy was observed in one affected individual. In association with hearing loss and movement abnormalities, we report a recurrent p.(Glu457Lys) substitution, previously documented in a neurologically impaired ATP2B2 mouse mutant. Our study further delineates the mutational spectrum and presentation of a human syndrome caused by ATP2B2 variants, confirming the importance of PMCA2 in neurotypical and cerebellar development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine and Health, Institute of Human Genetics, Technical University of Munich, Munich, Germany.
- Rady Children's Institute for Genomic Medicine, San Diego, California, USA.
- Division of Neurology, Rady Children's Hospital, San Diego, California, USA.
- Department of Neurosciences, University of California, La Jolla, California, USA.
- Department of Pediatrics, University of California, La Jolla, California, USA.
- Medical Reference Center for Inherited Metabolic Diseases, Jeanne de Flandre University Hospital, Lille, France.
ORCID-Profile: Jonathan Levy
Förderung
- EJP RD Joint Transnational Call 2022
- German Research Foundation
- Else Kröner-Fresenius-Stiftung
- Free State of Bavaria
- Technical University of Munich - Institute for Advanced Study
- German Federal Ministry of Education and Research (BMBF, Bonn, Germany)
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Stehr, A. M., Lenberg, J., Friedman, J., Dobbelaere, D., Imbard, A., Levy, J., Donoghue, S., Derive, N., Stoeva, R., Gueguen, P., & Zech, M. (2025). Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies. Clinical Genetics, 107(1), 91-97. https://doi.org/10.1111/cge.14622
Vancouver
Stehr AM, Lenberg J, Friedman J, Dobbelaere D, Imbard A, Levy J, et al. Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies. Clinical Genetics. 2025;107(1):91-97. doi:10.1111/cge.14622
BibTeX
@article{Stehr2025,
author = {Stehr, Antonia M and Lenberg, Jerica and Friedman, Jennifer and Dobbelaere, Dries and Imbard, Apolline and Levy, Jonathan and Donoghue, Sarah and Derive, Nicolas and Stoeva, Radka and Gueguen, Paul and Zech, Michael},
title = {Consolidating the Role of Mutated ATP2B2 in Neurodevelopmental and Cerebellar Pathologies},
journal = {Clinical Genetics},
year = {2025},
volume = {107},
number = {1},
pages = {91--97},
doi = {10.1111/cge.14622}
}
EUVIMED